ACTEnact Holdings, Inc.
Is the price fair?
At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Expensive vs its own history: P/E 9.7 vs a 6.8 median over 20 quarters (+42% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What ACT's price assumes
Enact Holdings, Inc. trades at 9.68× earnings against 8.72× for the median Insurance - Specialty name, more expensive than its own group.
Trailing P/E · Insurance - Specialty median 8.72 · 1.11× the median: the market pays up for this one
- Price / sales
- 5.00
Price / sales · as of 2026-Q2
- Price / book
- 1.16
Price / book · as of 2026-Q2
- EV / sales
- 5.19
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.16
- EV / salesas of 2026-Q2
- 5.19
- Financial Services median P/E625 names
- 12.1
- Insurance - Specialty median P/E14 names
- 8.72
- Market capitalisation
- $6.23B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $24.83 |
| Its own P/E history, median | $32.46 |
| Its own P/E history, upper quartile | $38.77 |
| 52-week range | $34.37 – $50.07 |
| Today | $45.98 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Insurance, Specialty
The closest names by size in the same industry